These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 23571182)

  • 1. Impact of scalp cooling on chemotherapy-induced alopecia, wig use and hair growth of patients with cancer.
    van den Hurk CJ; van den Akker-van Marle ME; Breed WP; van de Poll-Franse LV; Nortier JW; Coebergh JW
    Eur J Oncol Nurs; 2013 Oct; 17(5):536-40. PubMed ID: 23571182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness analysis of scalp cooling to reduce chemotherapy-induced alopecia.
    van den Hurk CJ; van den Akker-van Marle ME; Breed WP; van de Poll-Franse LV; Nortier JW; Coebergh JW
    Acta Oncol; 2014 Jan; 53(1):80-7. PubMed ID: 24059270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Scalp Cooling in Preventing Chemotherapy-Induced Alopecia in Breast Cancer Patients Receiving Adjuvant Docetaxel and Cyclophosphamide Chemotherapy.
    Cigler T; Isseroff D; Fiederlein B; Schneider S; Chuang E; Vahdat L; Moore A
    Clin Breast Cancer; 2015 Oct; 15(5):332-4. PubMed ID: 25749072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COOLHAIR: a prospective randomized trial to investigate the efficacy and tolerability of scalp cooling in patients undergoing (neo)adjuvant chemotherapy for early breast cancer.
    Smetanay K; Junio P; Feißt M; Seitz J; Hassel JC; Mayer L; Matthies LM; Schumann A; Hennigs A; Heil J; Sohn C; Jaeger D; Schneeweiss A; Marmé F
    Breast Cancer Res Treat; 2019 Jan; 173(1):135-143. PubMed ID: 30255454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between Use of a Scalp Cooling Device and Alopecia After Chemotherapy for Breast Cancer.
    Rugo HS; Klein P; Melin SA; Hurvitz SA; Melisko ME; Moore A; Park G; Mitchel J; Bågeman E; D'Agostino RB; Ver Hoeve ES; Esserman L; Cigler T
    JAMA; 2017 Feb; 317(6):606-614. PubMed ID: 28196257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scalp cooling for hair preservation and associated characteristics in 1411 chemotherapy patients - results of the Dutch Scalp Cooling Registry.
    van den Hurk CJ; Peerbooms M; van de Poll-Franse LV; Nortier JW; Coebergh JW; Breed WP
    Acta Oncol; 2012 Apr; 51(4):497-504. PubMed ID: 22304489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scalp cooling to prevent chemotherapy-induced hair loss: practical and clinical considerations.
    Mols F; van den Hurk CJ; Vingerhoets AJ; Breed WP
    Support Care Cancer; 2009 Feb; 17(2):181-9. PubMed ID: 18560904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonging the duration of post-infusion scalp cooling in the prevention of anthracycline-induced alopecia: a randomised trial in patients with breast cancer treated with adjuvant chemotherapy.
    Komen MMC; van den Hurk CJG; Nortier JWR; van der Ploeg T; Nieboer P; van der Hoeven JJM; Smorenburg CH
    Support Care Cancer; 2019 May; 27(5):1919-1925. PubMed ID: 30206728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of chemotherapy-induced alopecia.
    Yeager CE; Olsen EA
    Dermatol Ther; 2011; 24(4):432-42. PubMed ID: 21910801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scalp cooling: management option for chemotherapy-induced alopecia.
    Roe H
    Br J Nurs; 2014 Sep 11-24; 23(16):S4, S6, S8 passim. PubMed ID: 25203854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scalp cooling successfully prevents alopecia in breast cancer patients undergoing anthracycline/taxane-based chemotherapy.
    Vasconcelos I; Wiesske A; Schoenegg W
    Breast; 2018 Aug; 40():1-3. PubMed ID: 29660543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scalp hypothermia to prevent chemotherapy-induced alopecia is effective and safe: a pilot study of a new digitized scalp-cooling system used in 74 patients.
    Ridderheim M; Bjurberg M; Gustavsson A
    Support Care Cancer; 2003 Jun; 11(6):371-7. PubMed ID: 12768403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerance of a scalp-cooling system for prevention of hair loss and the experience of breast cancer patients treated by adjuvant chemotherapy.
    Protière C; Evans K; Camerlo J; d'Ingrado MP; Macquart-Moulin G; Viens P; Maraninchi D; Genre D
    Support Care Cancer; 2002 Oct; 10(7):529-37. PubMed ID: 12324807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a Scalp Cooling Device on Alopecia in Women Undergoing Chemotherapy for Breast Cancer: The SCALP Randomized Clinical Trial.
    Nangia J; Wang T; Osborne C; Niravath P; Otte K; Papish S; Holmes F; Abraham J; Lacouture M; Courtright J; Paxman R; Rude M; Hilsenbeck S; Osborne CK; Rimawi M
    JAMA; 2017 Feb; 317(6):596-605. PubMed ID: 28196254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of the Dutch scalp cooling registry in 7424 patients: analysis of determinants for scalp cooling efficacy.
    Brook TS; Seetsen T; Dercksen MW; van Riel A; Derleyn VA; van den Bosch J; Nortier JWR; Collett A; Georgopoulos NT; Bryk J; Breed WPM; Van Den Hurk CJG
    Oncologist; 2024 Oct; 29(10):e1386-e1395. PubMed ID: 38869252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of 20- versus 45-min post-infusion scalp cooling time in the prevention of docetaxel-induced alopecia.
    Komen MM; Breed WP; Smorenburg CH; van der Ploeg T; Goey SH; van der Hoeven JJ; Nortier JW; van den Hurk CJ
    Support Care Cancer; 2016 Jun; 24(6):2735-41. PubMed ID: 26805558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scalp cooling for hair loss prevention in female Japanese breast cancer patients receiving (neo)adjuvant chemotherapy.
    Ohsumi S; Kiyoto S; Takahashi M; Hara F; Takashima S; Aogi K; Matsuda M; Yamamura N; Doi M
    Support Care Cancer; 2021 Jan; 29(1):437-443. PubMed ID: 32388615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of scalp cooling system in preventing chemotherapy induced alopecia - A single center prospective study.
    Kate S; Patil R; Pathan D; Vyavhare R; Joseph S; Baby V; Ramesh YV; Nagarkar R
    Cancer Treat Res Commun; 2021; 26():100280. PubMed ID: 33338853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient-reported outcome assessment and objective evaluation of chemotherapy-induced alopecia.
    Komen MMC; van den Hurk CJG; Nortier JWR; van der Ploeg T; Smorenburg CH; van der Hoeven JJM
    Eur J Oncol Nurs; 2018 Apr; 33():49-55. PubMed ID: 29551177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Clinical and Biological Guide for Understanding Chemotherapy-Induced Alopecia and Its Prevention.
    Dunnill CJ; Al-Tameemi W; Collett A; Haslam IS; Georgopoulos NT
    Oncologist; 2018 Jan; 23(1):84-96. PubMed ID: 28951499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.